Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 764 across all filing types
Latest filing 2026-03-12 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
VOLUNTARY TERMINATION OF THE SUBSEQUENT LISTING OF SICHUAN RUIJIAN MEDICAL ON BEIJING STOCK EXCHANGE
Regulatory Filings Classification · 1% confidence The document is an announcement from PW Medtech Group Limited regarding the voluntary termination of a subsidiary's (Sichuan Ruijian Medical) application for a subsequent listing on the Beijing Stock Exchange. This is a corporate announcement regarding a strategic capital market decision and does not fit into specific categories like M&A (TAR) or Delisting (DLST) as it pertains to a subsidiary's application status rather than the parent company's primary listing. Therefore, it is classified as a general regulatory announcement.
2026-03-12 English
PROFIT WARNING
Earnings Release Classification · 1% confidence The document is a 'Profit Warning' announcement issued by PW Medtech Group Limited. It provides preliminary, unaudited financial expectations for the fiscal year ended December 31, 2025, in compliance with Rule 13.09 of the Listing Rules and the Inside Information Provisions of the SFO. While it contains financial figures, it is an initial announcement of results rather than the full audited annual report or a comprehensive earnings release, and it does not fit into the other specific categories like M&A or governance. Therefore, it is classified as a Regulatory Filing (RNS). FY 2025
2026-03-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2026
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, including share capital, treasury shares, and share repurchases. Since it is a recurring regulatory filing regarding share capital and movements, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Share Issue' (which usually refers to new capital raises) or 'Transaction in Own Shares' (which is a specific subset of this broader monthly return).
2026-03-04 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' filed with the Hong Kong Stock Exchange. It explicitly details changes in issued shares, treasury shares, and share repurchases (buybacks). According to the filing definitions, reports of a company buying back its own shares fall under the 'Transaction in Own Shares' (POS) category.
2026-02-24 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' filed with the Hong Kong Stock Exchange. It details changes in issued shares, treasury shares, and specifically lists shares repurchased for cancellation. According to the filing definitions, reports regarding a company buying back or selling its own shares (share repurchase) fall under the 'Transaction in Own Shares' (POS) category.
2026-02-23 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' from the Hong Kong Stock Exchange, which is a standard regulatory filing used to report changes in issued shares, treasury shares, or share repurchases. Specifically, the document details share repurchases for cancellation. According to the provided definitions, 'Transaction in Own Shares' (POS) is the correct category for reports of a company buying back its own shares.
2026-02-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.